Proceedings of the National Academy of Sciences · 2019 · 137 citations · 35 references
Life SciencesNeurosciencePharmacologyCellular NeuroscienceMolecular NeuroscienceNeuropharmacologyAnalgesiaNeuropathic PainPain MechanismsPain ModulationPain NeurobiologyPain NeuroscienceAnti-inflammatory Cytokine ModulationInflammation-pain CouplingNeuropathic Pain ModulationNon-opioid AnalgesiaPain Pathway ModulationPain Signaling PathwaysSphingosine 1-Phosphate Receptor ModulationSphingosine-1-phosphate Signaling
Significance Understanding the cellular and molecular pathways of neuropathic pain is fundamental to discovering classes of non-opioid analgesics. Emerging evidence implicates altered sphingolipid metabolism and elevated levels of sphingosine-1-phosphate (S1P) in the spinal cord in the persistence of neuropathic pain, but its neuropharmacology and pathways engaged are poorly understood. Using a multidisciplinary approach, we provide evidence that S1P drives neuropathic pain by selectively activating the S1P receptor subtype 1 (S1PR1) in astrocytes. Inhibiting S1PR1 attenuated and reversed neuropathic pain by engaging the potent anti-inflammatory cytokine, interleukin 10. Our findings represent a paradigm shift in the understanding of S1PR1 signaling that has implications on the future development of S1PR1 antagonists as a promising class of nonnarcotic analgesics.
35
Quantitative assessment of tactile allodynia in the rat paw
Sandra R. Chaplan, Flemming W. Bach, J W Pogrel et al. · Journal of Neuroscience Methods · 1994 · 7.9K citations
Spared nerve injury: an animal model of persistent peripheral neuropathic pain
Isabelle Décosterd, Clifford J. Woolf · Pain · 2000 · 2.3K citations
Medicine, Neurology, Neuroscience +16